Total Funding
22
62
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
150366
Ambra BioScience LLC - Lovidia is a proprietary gut sensory modulation technology platform.
- Martin Brown: Chief Executive Officer and Co-FounderPast Role: Elcelyx Therapeutics, Chief Business Officer
About the Company
Ambra BioScience LLC - Lovidia is a proprietary Gut Sensory Modulation Technology Platform used to create medical meals and dietary supplements that address important health and wellness issues, like preserving a healthy weight and blood sugar levels. They were concerned with the hormones that the L cells in the lower gut normally release. GLP-1,
PYY, and oxyntomodulin are released when the nutrients in food naturally stimulate the bitter, umami, and sweet taste receptors found on the luminal side of the L-cells. These hormones have an impact on mood, glucose regulation, inflammation, and the regulation of hunger and fullness.
